Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy.
Journal: Drug design, development and therapy
Published: February 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Journal: British journal of cancer
Published: January 21, 2019
EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil.
Journal: The oncologist
Published: April 27, 2018
Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection.
Journal: Journal for immunotherapy of cancer
Published: March 26, 2018
Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin.
Journal: BMJ case reports
Published: March 11, 2018
Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting.
Journal: Lung Cancer (Auckland, N.Z.)
Published: November 02, 2017
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
Journal: Clinical lung cancer
Published: September 22, 2017
The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.
Journal: The oncologist
Published: March 10, 2017
Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 02, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026